摘要
目的:探讨GRK6对多发性骨髓瘤细胞增殖作用的调控及其机制。方法:通过构建干扰人GRK6基因的慢病毒载体GRK6-shRNA,转染筛选获得稳定下调GRK6基因表达的多发性骨髓瘤细胞株MM1R。利用实时定量PCR及Westem blot验证慢病毒载体介导的GRK6基因表达下调的效果。选取GRK6表达下调最显著的细胞株检测GRK6对细胞增殖的影响。结果:构建干扰人GRK6基因的慢病毒载体GRK6-shRNA,转染多发性骨髓瘤MM1R细胞,筛选并获得稳定下调GRK6基因的多发性骨髓瘤细胞株MM1R。CCK-8试验结果显示,实验组细胞增殖活性明显低于对照组(P<0.05)。流式细胞术检测显示:实验组细胞在G0/G1期被阻滞(P<0.05)。Western Blot检测实验组Cyclin D1和CDK4水平相比较对照组明显降低。结论:成功构建了特异性干扰GRK6表达的慢病毒载体,获得可稳定下调GRK6的MM1R细胞株并且发现下调GRK6表达后,MM1R细胞可能通过抑制Cyclin D1和CDK4水平使MM1R细胞阻滞于G0/G1期,并显著地抑制了多发性骨髓瘤MM1R细胞的增殖。
Objective:To explore the regulatory effect of GRK6 on the proliferation of multiple myeloma cells and its mechanism.Methods:A lentivirus vector shRNA interfering in human GRK6 gene expression was constructed and transfected into multiple myeloma cells to obtain the cell line MMIR with stable down-regulation of GRK6 gene expression.The real-time quantitative PCR and Western blot were used to confirm the effectiveness of the GRK6 gene expression down-regulation mediated by lentivirus vector.The MMIR cells with most obvious down-regulation were selected to detect the effect of GRK6 gene on cell proliferation.Results:The lentivirus vector GRK6-shRNA interfering in human GRK6 gene was constructed succesufully and transfected into multiple myeloma cells,thereby the MMIR cell line with stable down-regulation of GRK6 gene was obtained.The CCK-8 assay showed that the proliferative viability of MMIR cells in experimental group was significantly lower than that in control group(P〈0.05);the flow cytometry showed that cells in experimental group were arrested in G0/G1 phase(P〈0.05);the Western blot detection showed that the Cyclin D1 and CDK4 levels in experiment group obviously decreased as compared with control group.Conclusion:A lentivirus vector which can specifically interfere in GRK6 gene expression is constructed successfully,The MMIR cell line with stable down-regulation of GRK6 expression is obtained by transfection and screening.The down-regulation of GRK6 expression can arrest MMIR cells in G0/G1 phase,moreover inhibits the proliferation of MMIR cells by inhibition of Cyclin D1 and CDK4 levels.
出处
《中国实验血液学杂志》
CAS
CSCD
北大核心
2016年第5期1421-1426,共6页
Journal of Experimental Hematology